Firmagon (degarelix) - Astellas, Ferring
gridegalutamide (BMS-986365) - BMS
Sotyktu (deucravacitinib) - BMS
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer (clinicaltrials.gov) - Sep 12, 2026 - P2 | N=7 | Active, not recruiting | Sponsor: Memorial Sloan Kettering Cancer Center | N=30 ➔ 7 | Recruiting ➔ Active, not recruiting 
Enrollment change • Enrollment closed • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07335796
 
Sep 12, 2026
 
Prev Next